Fate Therapeutics Price Chart
Fate Therapeutics Volume Chart
Fate Therapeutics Market Segments
After Hours
+0.01(+0.63%)
| Open | $1.39 |
|---|---|
| Close | $1.40 |
| Low | $1.38 |
| Low Change | -0.01 (-0.81%) |
| High | $1.40 |
| High Change | +0.01 (+0.63%) |
| Range | $0.02 |
| Volume | 5.329K |
| Dollar Volume | $7.46K |
Regular Trading Hours
+0.00(+0.00%)
| Open | $1.40 |
|---|---|
| Close | $1.40 |
| Low | $1.35 |
| Low Change | -0.05 (-3.57%) |
| High | $1.42 |
| High Change | +0.02 (+1.43%) |
| Range | $0.07 |
| Volume | 1.818M |
| Dollar Volume | $2.55M |
Premarket
+0.03(+2.17%)
| Open | $1.38 |
|---|---|
| Close | $1.41 |
| Low | $1.37 |
| Low Change | -0.01 (-0.72%) |
| High | $1.42 |
| High Change | +0.04 (+2.90%) |
| Range | $0.05 |
| Volume | 22.611K |
| Dollar Volume | $31.88K |
After Hours Yesterday
-0.01(-0.46%)
| Open | $1.35 |
|---|---|
| Close | $1.34 |
| Low | $1.33 |
| Low Change | -0.02 (-1.48%) |
| High | $1.35 |
| High Change | +0.00 (+0.00%) |
| Range | $0.02 |
| Volume | 1.71K |
| Dollar Volume | $2.30K |
Regular Trading Hours Yesterday
+0.10(+7.81%)
| Open | $1.28 |
|---|---|
| Close | $1.38 |
| Low | $1.28 |
| Low Change | 0.00 (0.00%) |
| High | $1.39 |
| High Change | +0.11 (+8.20%) |
| Range | $0.11 |
| Volume | 1.175M |
| Dollar Volume | $1.62M |
Premarket Yesterday
+0.03(+2.31%)
| Open | $1.30 |
|---|---|
| Close | $1.33 |
| Low | $1.26 |
| Low Change | -0.04 (-3.08%) |
| High | $1.33 |
| High Change | +0.03 (+2.31%) |
| Range | $0.07 |
| Volume | 3.122K |
| Dollar Volume | $4.15K |
Fate Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.31 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.26 |
| 20 Day Moving Average (SMA20) | $1.21 |
| 50 Day Moving Average (SMA50) | $1.27 |
| 100 Day Moving Average (SMA100) | $1.18 |
| 200 Day Moving Average (SMA200) | $1.17 |
Fate Therapeutics Statistics
| Average Volume (30 Days) | 1.41M |
|---|---|
| P/E Ratio (Current) | -1.10 |
| EPS (Current) | -$1.17 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$112.04M |
| Cash Ratio | 1.29 |
| Current Ratio | 5.79 |
| Quick Ratio | 5.79 |
| Debt to Equity | 0.00 |
| Enterprise Value | $103.35M |
| EV to EBITDA | -0.77 |
| EV to Sales | 15.55 |
| Price to Book | 0.72 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 22.57 |
| Return on Assets | -0.43% |
| Return on Equity | -0.66% |
Fate Therapeutics Stock Splits
There have been no stock splits for Fate Therapeutics (FATE).
Fate Therapeutics Dividends
There have been no dividends for Fate Therapeutics (FATE).